![Helen Collins](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Helen Collins
Technik-/Wissenschafts-/F&E-Leiter bei
ENLIVEN THERAPEUTICS, INC.
Vermögen: 989 250 $ am 31.05.2026
Profil
Helen Collins is the founder of North Bay Cancer Alliance, Inc., founded in 2005.
Current jobs include Independent Director at Kura Oncology, Inc. since 2021 and Chief Medical Officer at Enliven Therapeutics, Inc. since 2023.
Former jobs include Independent Director at IO Biotech, Inc. from 2023 to 2026; Chief Medical Officer & Executive Vice President at Five Prime Therapeutics, Inc. from 2019 to 2021; President at Redwood Regional Medical Group, Inc. from 2006 to 2009; Lead Global Head-Oncology Biosimilars at Amgen, Inc.; and Head-Lead Clinical & Program at Gilead Sciences, Inc. Education includes an undergraduate degree from Bryn Mawr College in 1984 and a doctorate from The Johns Hopkins University School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 17.06.2026 | 25’000 ( 0.04% ) | 989 250 $ | 31.05.2026 | |
KURA ONCOLOGY, INC. -.--% | 04.06.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Helen Collins
| Unternehmen | Position | Beginn |
|---|---|---|
| KURA ONCOLOGY, INC. | Direktor/Vorstandsmitglied | 29.07.2021 |
| ENLIVEN THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 23.02.2023 |
Ehemalige bekannte Positionen von Helen Collins
| Unternehmen | Position | Ende |
|---|---|---|
| IO BIOTECH, INC. | Direktor/Vorstandsmitglied | 31.03.2026 |
| FIVE PRIME THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 16.04.2021 |
Redwood Regional Medical Group, Inc.
 Redwood Regional Medical Group, Inc. Medical/Nursing ServicesHealth Services Provides medical radiology, oncology, orthopedics, and surgey services | Präsident | 01.01.2009 |
| AMGEN INC. | Corporate Officer/Principal | - |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | - |
Ausbildung von Helen Collins
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
32
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Five Prime Therapeutics, Inc.
 Five Prime Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops protein therapeutics for cancer and inflammatory diseases | Health Technology |
Kura Oncology, Inc.
 Kura Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Bryn Mawr College
 Bryn Mawr College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Redwood Regional Medical Group, Inc.
Redwood Regional Medical Group, Inc. Medical/Nursing ServicesHealth Services Provides medical radiology, oncology, orthopedics, and surgey services | Health Services |
The Johns Hopkins University School of Medicine
 The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
North Bay Cancer Alliance, Inc.
 North Bay Cancer Alliance, Inc. Miscellaneous Commercial ServicesCommercial Services Provides individual and family social services | Commercial Services |
IO Biotech, Inc.
 IO Biotech, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel, immune-modulating cancer therapies | Health Technology |
Enliven Therapeutics, Inc.
 Enliven Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage precision oncology company that develops molecule therapies | Health Technology |
